Owkin
Jean-Frederic Petit-Nivard is an experienced professional who has held various roles in companies such as Owkin, Roche, SYSNAV, and Pochet du Courval. Jean-Frederic has also worked at Bain & Company, Pernod Ricard, and Financière de l'Echiquier. With a strong educational background from institutions like École Polytechnique, MIT, and Saïd Business School, University of Oxford, Jean-Frederic has expertise in areas such as management research, mathematics, engineering, and big data analytics. Additionally, as a Lieutnant in the Ecole Militaire de Haute Montagne, Jean-Frederic modernized and instructed theoretical courses for alpine cadets.
This person is not in any offices
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.